The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia

Brain Research Bulletin

Volumn 57, Issue 2, 2002, Pages 133-150

  Tassonyi, Edömer ^a,b   Charpantier, Eric ^b   Muller, Dominique ^b   Dumont, Lionel ^a   Bertrand, Daniel ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Anesthesia; Anesthetic agents; Molecular mechanisms; Nicotinic acetylcholine receptors

Indexed keywords

3 (2 AZETIDINYLMETHOXY)PYRIDINE; 4 AMINOBUTYRIC ACID A RECEPTOR; 5 (2 AZETIDINYLMETHOXY) 2 CHLOROPYRIDINE; ATRACURIUM; BARBITURIC ACID DERIVATIVE; CURARE; ENFLURANE; EPIBATIDINE; ETHER; ETOMIDATE; FENTANYL; GLYCINE RECEPTOR; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; KETAMINE; METHOHEXITAL; METHOXYFLURANE; NICOTINIC RECEPTOR; PANCURONIUM; PENTOBARBITAL; PROPOFOL; RECEPTOR SUBUNIT; SEROTONIN RECEPTOR; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL; TUBOCURARINE CHLORIDE; UNINDEXED DRUG; VECURONIUM;

ADRENERGIC TRANSMISSION; ANALGESIA; ANESTHESIA; BEHAVIOR; BINDING SITE; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; HIPPOCAMPUS; HUMAN; HYPOTENSION; IC 50; MOLECULAR BIOLOGY; MUSCLE RELAXATION; NEUROMUSCULAR SYNAPSE; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR SENSITIVITY; REVIEW;

ACETYLCHOLINE; ANALGESICS; ANESTHESIA; ANESTHETICS; ANESTHETICS, INHALATION; ANIMALS; BINDING, COMPETITIVE; CENTRAL NERVOUS SYSTEM; CONSCIOUSNESS; COTURNIX; DRUG SYNERGISM; HUMANS; ION CHANNEL GATING; KETAMINE; MICE; MODELS, MOLECULAR; MUSCLE PROTEINS; MUSCLE RELAXANTS, CENTRAL; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; PAIN; PERIPHERAL NERVOUS SYSTEM; PROTEIN SUBUNITS; RATS; RECEPTORS, NICOTINIC; RECOMBINANT FUSION PROTEINS; SYNAPTIC TRANSMISSION;

EID: 0037081827     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00740-7     Document Type: Review

References (200)

1. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors
2. Drug blockade of open end-plate channels
3. Intercellular communication in the brain: Wiring versus volume transmission
4. Nicotinic acetylcholine receptors on hippocampal neurons: Distribution on the neuronal surface and modulation of receptor activity
5. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes
6. Mapping the location of functional nicotinic and gamma-aminobutyric acidA receptors on hippocampal neurons
7. Alpha-bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices
8. Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices
9. Nicotinic receptor activation in human cerebral cortical interneurons: A mechanism for inhibition and disinhibition of neuronal networks
10. Differential effects of thiopental on neuronal nicotinic acetylcholine receptors and P2X purinergic receptors in PC12 cells
11. Epibatidine, a potent analgetic and nicotinic agonist
12. Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors
13. Central nicotinic receptors: Vomiting, ear twitching and panting
14. Role of the nucleus raphe magnus in antinociception produced by ABT-594: Immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons
15. Claude bernard on the action of curare
16. A synaptic model of memory: Long-term potentiation in the hippocampus
17. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine
18. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction
19. Presynaptic receptors in the neuromuscular junction
20. Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats
21. Isoflurane causes "flickering" of the acetylcholine receptor channel: Observations using the patch clamp
22. Developmental expression of alpha 7 neuronal nicotinic receptor messenger RNA in rat sensory cortex and thalamus
23. Block of nicotinic acetylcholine-activated channels of cultured mouse myotubes by isoflurane
24. Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine
25. Activation of brain acetylcholine receptors by neuromuscular blocking drugs. A possible mechanism of neurotoxicity
26. Human neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes predict efficacy of halogenated compounds that disobey the Meyer-Overton rule
27. Anaesthetic modulation of nicotinic ion channel kinetics in bovine chromaffin cells
28. Blockade and activation of the human neuronal nicotinic acetylcholine receptors by atracurium and laudanosine
29. Effects of neuromuscular blocking agents on excitatory transmission and gamma-aminobutyric acidA-mediated inhibition in the rat hippocampal slice
30. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: Mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release
31. French survey of anesthesia in 1996
32. The effect of tubocurarine competition on the kinetics of agonist action on the nicotinic receptor
33. Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions
34. Nicotinic receptors at the amino acid level
35. Neurons in culture maintain acetylcholine receptor levels with far fewer transcripts than in vivo
36. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX
37. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats
38. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model
39. d-Tubocurarine causes neuronal death when injected directly into the rat brain
40. The role of neuronal nicotinic acetylcholine receptors in antinociception: Effects of ABT-594
41. Therapeutic potential of neuronal nicotinic acetylcholine receptor agonists as novel analgesics
42. A study of curare action with an electrical micro-method
43. The effects of temperature on the interactions between volatile general anaesthetics and a neuronal nicotinic acetylcholine receptor
44. Basic pharmacology of inhalational anesthetic agents
45. Actions of volatile anesthetics and alcohols on cholinergic receptor channels
46. Effects of isoflurane on acetylcholine receptor channels. 1. Single-channel currents
47. Interactions of general anaesthetics with single acetylcholine receptor channels
48. Evidence for direct actions of general anesthetics on an ion channel protein. A new look at a unified mechanism of action
49. Potentiation of succinylcholine phase II block with isoflurane
50. Effects of thiopental and its optical isomers on nicotinic acetylcholine receptors
51. An inhalational anesthetic binding domain in the nicotinic acetylcholine receptor
52. Concentrations of atracurium and laudanosine in cerebrospinal fluid and plasma during intracranial surgery
53. Alpha 9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells
54. Alpha 10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells
55. Regulation of alpha4beta2 nicotinic receptor desensitization by calcium and protein kinase C
56. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO
57. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors
58. Intravenous anesthetics differentially modulate ligand-gated ion channels
59. Alpha 4 beta 2 neuronal nicotinic acetylcholine receptors in the central nervous system are inhibited by isoflurane and propofol, but alpha 7-type nicotinic acetylcholine receptors are unaffected
60. Rapid tracheal intubation with non-depolarizing neuromuscular blocking drugs: The priming principle
61. A discrete site for general anesthetics on a postsynaptic receptor
62. Nonanesthetic volatile drugs obey the Meyer-Overton correlation in two molecular protein site models
63. Anesthetic effects on blood-brain barrier function during acute arterial hypertension
64. Do general anaesthetics act by competitive binding to specific receptors?
65. Neuron membranes: Anaesthetics on the mind
66. Stereospecific effects of inhalational general anesthetic optical isomers on nerve ion channels
67. Molecular and cellular mechanisms of general anaesthesia
68. Which molecular targets are most relevant to general anaesthesia?
69. Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells
70. Stereospecific interaction of ketamine with nicotinic acetylcholine receptors in human sympathetic ganglion-like SH-SY5Y cells
71. Interaction of intravenous anesthetics with human neuronal potassium currents in relation to clinical concentrations
72. Inhibition of nicotine-induced hippocampal norepinephrine release in rats by alpha-conotoxins MII and AuIB microinjected into the locus coeruleus
73. Local alpha-bungarotoxin-sensitive nicotinic receptors modulate hippocampal norepinephrine release by systemic nicotine
74. Interaction of magnesium sulphate with vecuronium-induced neuromuscular block
75. The neuronal alpha6 subunit forms functional heteromeric acetylcholine receptors in human transfected cells
76. Acute and chronic nicotine exposure differentially facilitate the induction of LTP
77. Nicotine reverses GABAergic inhibition of long-term potentiation induction in the hippocampal CA1 region
78. Transmitters involved in antinociception in the spinal cord
79. The effects of ketamine and propofol on neuronal nicotinic acetylcholine receptors and P2x purinoceptors in PC12 cells
80. Alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors
81. Accidental subarachnoid injection of gallamine. A case report
82. Hippocampal synaptic transmission enhanced by low concentrations of nicotine
83. The use of curare in genral anesthesia
84. A reporter mutation approach shows incorporation of the "orphan" subunit beta3 into a functional nicotinic receptor
85. Suxamethonium-induced cardiac arrest and death following 5 days of immobilization
86. Synaptic transmission at nicotinic acetylcholine receptors in rat hippocampal organotypic cultures and slices
87. Pharmacology of laudanosine in dogs
88. Interaction of midazolam with the nicotinic acetylcholine receptor of mouse myotubes
89. Bidirectional synaptic plasticity induced by a single burst during cholinergic theta oscillation in CA1 in vitro
90. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus
91. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin
92. Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons
93. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity
94. Functional nicotinic ACh receptors on interneurones in the rat hippocampus
95. Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins
96. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain
97. Racemic ketamine decreases muscle sympathetic activity but maintains the neural response to hypotensive challenges in humans
98. Intrathecal neostigmine for post-cesarean section analgesia: Dose response
99. On the reactions of cells and of nerve endings to certain poisons, chiefly as regards the reaction of striated muscle to nicotine and to curare
100. Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain
101. Differential mechanisms involved in the effect of nicotinic agonists DMPP and lobeline to release [3H]5-HT from rat hippocampal slices
102. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion
103. Clinical pharmacology and applications of neuromuscular blockers
104. Acetylcholine receptors and myasthenia
105. Alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release
106. Effect of ketamine on transmission in sympathetic ganglia
107. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular
108. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
109. Cerebrospinal fluid levels of d-tubocurarine in man
110. Effects of apamin and nicotinic acetylcholine receptor antagonists on inferior collicular seizures
111. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
112. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons
113. Actions of general anaesthetics on a neuronal nicotinic acetylcholine receptor in isolated identified neurones of Lymnaea stagnalis
114. Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus
115. Theorie der alkoholnarkose
116. The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain
117. A stereoselective pentobarbital binding site in cholinergic membranes from Torpedo californica
118. Nicotinic acetylcholine receptor at 4.6 A resolution: Transverse tunnels in the channel wall
119. Basic pharmacology of ketamine
120. Ion channel modulation as the basis for general anesthesia
121. Pentobarbital: Differential postsynaptic actions on sympathetic ganglion cells
122. The effect of ketamine on the peripheral circulation: A possible sympathetic ganglion blocking effect
123. Nicotinic receptors are regulated by protein kinase C activated via a nicotinic receptors-mediated signaling pathway
124. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents
125. Intrathecal clonidine alleviates allodynia in neuropathic rats: Interaction with spinal muscarinic and nicotinic receptors
126. Long-term desensitization of nicotinic acetylcholine receptors is regulated via protein kinase A-mediated phosphorylation
127. Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: A behavioral characterization of Acra7-deficient mice
128. Accidental subarachnoid injection of pancuronium
129. Psychometric changes as well as analgesic action and cardiovascular adverse effects of ketamine racemate versus s-(+)-ketamine in subanesthetic doses
130. Nicotinic receptors in the brain. Links between molecular biology and behavior
131. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain
132. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine
133. Pipecuronium-induced neuromuscular blockade during nitrous oxide- fentanyl, isoflurane, and halothane anesthesia in adults and children
134. Alterations in modulation of acetylcholine release following lesion of hippocampal cholinergic neurons with the neurotoxin AF64A
135. Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission
136. Nicotinic modulation of glutamate and GABA synaptic transmission of hippocampal neurons
137. General anesthetics modify the kinetics of nicotinic acetylcholine receptor desensitization at clinically relevant concentrations
138. The alkyl chain dependence of the effect of normal alcohols on agonist- induced nicotinic acetylcholine receptor desensitization kinetics
139. Isoflurane increases the apparent agonist affinity of the nicotinic acetylcholine receptor
140. Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels
141. The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts
142. Nicotinic receptors in the development and modulation of CNS synapses
143. Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity
144. Physostigmine reversal of diazepam
145. Central anticholinergic syndrome in anesthetic practice
146. Expression of neuronal nicotinic acetylcholine receptor subunit genes in the rat autonomic nervous system
147. Nonstereoselective inhibition of neuronal nicotinic acetylcholine receptors by ketamine isomers
148. Pharmacology of muscle relaxants and their antagonists
149. Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state
150. Isoflurane and sevoflurane interact with the nicotinic acetylcholine receptor channels in micromolar concentrations
151. Molecular cloning, functional properties, and distribution of rat brain alpha 7: A nicotinic cation channel highly permeable to calcium
152. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus
153. Pharmacokinetics of neuromuscular blockers
154. Presence of nicotinic acetylcholine receptors in cat carotid body afferent system
155. Opiates and potent analgesics
156. A new class of alkaloids from a dendrobatid poison frog: A structure for alkaloid 251F
157. Antagonist and partial agonist actions of d-tubocurarine at mammalian muscle acetylcholine receptors
158. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors
159. Selective actions of intravenous anesthetics on nicotinic- and muscarinic-receptor-mediated responses of the dog adrenal medulla
160. Regulation of ligand-gated ion channels by protein phosphorylation
161. Central nervous system effects of intrathecal muscle relaxants in rats
162. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain - An in vivo microdialysis study
163. Cerebrospinal fluid concentrations of atracurium and laudanosine in neurosurgical patients
164. Postoperative apnoea following nivalin administration
165. Lesion with the neurotoxin AF64A alters hippocampal cholinergic receptor function
166. Preparation of barbiturate optical isomers and their effects on GABA(A) receptors
167. Curare can open and block ionic channels associated with cholinergic receptors
168. Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscle
169. Nicotinic acetylcholine receptor at 9 A resolution
170. Acetylcholine receptor channel imaged in the open state
171. Differential sensitivities of mammalian neuronal and muscle nicotinic acetylcholine receptors to general anesthetics
172. Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system
173. Neurochemistry and pharmacology of the major hippocampal transmitter systems: Synaptic and nonsynaptic interactions
174. Side effects of nondepolarizing muscle relaxants: Relationship to their antinicotinic and antimuscarinic actions
175. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors
176. Prejunctional modulation of acetylcholine release from the skeletal neuromuscular junction: Link between positive (nicotinic)- and negative (muscarinic)-feedback modulation
177. Tubocurarine and pancuronium inhibit evoked release of acetylcholine from the mouse hemidiaphragm preparation
178. Intracellular regulation of neuronal nicotinic cholinoreceptors
179. Relative potencies of volatile anesthetics in altering the kinetics of ion channels in BC3H1 cells
180. Mechanism of volatile anesthetic action on ion channels
181. Kinetics of nicotinic acetylcholine ion channels in the presence of intravenous anaesthetics and induction agents
182. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat
183. Presynaptic nicotine receptors mediating a positive feed-back on transmitter release from the rat phrenic nerve
184. Hippocampal nicotinic autoreceptors modulate acetylcholine release
185. Presynaptic nicotinic ACh receptors
186. Cholinergic excitation of septohippocampal GABA but not cholinergic neurons: Implications for learning and memory
187. Carotid body chemoreceptor function is impaired by vecuronium during hypoxia
188. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor
189. Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors
190. Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine
191. Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol
192. Effects of nicotine, pilocarpine, and tetrahydroaminoacridine on hippocampal theta waves in freely moving rabbits
193. Distributions of nicotinic acetylcholine receptor alpha7 and beta2 subunits on cultured hippocampal neurons
194. Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons
195. Volatile general anaesthetic actions on recombinant nACh alpha 7, 5-HT3 and chimeric nACh alpha 7-5-HT3 receptors expressed in Xenopus oocytes
196. The n-alcohol site in the nicotinic receptor pore is a hydrophobic patch
197. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems
198. Identification of four classes of brain nicotinic receptors using beta2 mutant mice
199. Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors